-
Hydroxychloroquine in Stage 1 Type 1 Diabetes.
Diabetes CareLibman I, Bingley PJ, Becker D, Buckner JH, DiMeglio LA, Gitelman SE, Greenbaum C, Haller MJ, Ismail HM, Krischer J, Moore WV, Moran A, Muir AB, Raman V, Steck AK, Toledo FGS, Wentworth J, Wherrett D, White P, You L, Herold KC, Type 1 Diabetes TrialNet Study Group -
T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients with Inflammatory Bowel Disease.
Cell Mol Gastroenterol HepatolWilliams KG, Kongala R, Shows DM, Konecny AJ, Hindmarch DC, Clarke AS, Lord JD -
High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment.
DiabetologiaSims EK, Geyer SM, Long SA, Herold KC -
MicroMagnify: A Multiplexed Expansion Microscopy Method for Pathogens and Infected Tissues.
Adv Sci (Weinh)Cheng Z, Stefani C, Skillman T, Klimas A, Lee A, DiBernardo EF, Brown KM, Milman T, Wang Y, Gallagher BR, Lagree K, Jena BP, Pulido JS, Filler SG, Mitchell AP, Hiller NL, Lacy-Hulbert A, Zhao Y -
OGTT metrics surpass continuous glucose monitoring data for T1D prediction in multiple-autoantibody-positive individuals.
J Clin Endocrinol MetabYlescupidez A, Speake C, Pietropaolo SL, Wilson DM, Steck AK, Sherr JL, Gaglia JL, Bender C, Lord S, Greenbaum CJ -
Editorial: Processing, presentation, and recognition of T cell determinants: From molecular insights to clinical applications.
Cell ImmunolJames EA -
Characterizing Regionalization of Inflammatory Bowel Disease Hospitalizations and Operations in Washington State.
J Gastrointest SurgStovall SL, Soriano CR, Kaplan JA, La Selva D, Lord J, Moonka R, Zisman TL, Simianu VV -
Immune-related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity.
Immunol RevSingh N, Hocking AM, Buckner JH -
Ara h 2 Peptide Mix Improves the Diagnosis of Peanut Allergy and Is Relevant for Ara h 2-Induced Mast Cell Activation.
J Allergy Clin Immunol PractKwok M, Evans E, Hemmings O, Marknell DeWitt Å, O'Rourke C, Bahnson HT, Lack G, Santos AF -
Dual-locus, dual-HDR editing permits efficient generation of antigen-specific, regulatory T cells with robust suppressive activity.
Mol TherHunt MS, Yang SJ, Mortensen E, Boukhris A, Buckner J, Cook PJ, Rawlings DJ -
Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study.
J Clin Endocrinol MetabEttinger RA, Buitinga M, Vandamme C, Afonso G, Gomez R, Arribas-Layton D, Bissenova S, Speake C, Reijonen H, Kinnunen T, Overbergh L, Mallone R, Kwok WW, James EA -
Commentary on a Classic JHC Article on Intracellular Hyaluronan Associated with the Mitotic Spindle.
J Histochem CytochemEvanko SP, Wight TN -
Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy.
J Allergy Clin ImmunolAltman MC, Segnitz RM, Larson D, Jayavelu ND, Smith M, Patel S, Scadding GW, Qin T, Sanda S, Steveling E, Eifan AO, Penagos M, Jacobson MR, Parkin RV, Shamji MH, Togias A, Durham SR -
Latent EBV impairs immune cell signaling and enhances the efficacy of anti-CD3 mAb in Type 1 Diabetes.
medRxivDelgado AL, Preston-Hurlburt P, Lim N, Sumida TS, Long SA, McNamara J, Serti E, Higdon L, Herold KC -
Where are Colorectal Resections being Performed? Colon and Rectal Cancer Operations in Washington State are Decentralized.
J Gastrointest SurgSoriano CR, Evans E, Lin BS, Kaplan JA, Post AB, Bahnson HT, Simianu VV
